Please assess the completion status of the following clinical trial:

Trial Title: Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patient with newly diagnosed brain metastases~* Patient with cancer regardless of the type of primary cancer, with anatomopathological proof~* At least, one measurable lesion ≥ 10 mm on the MRI T1 gadolinium sequences~* Number of brain metastases lower or equal to 5~* Indication of radiosurgery treatment~* Age ≥ 18 years old~* ECOG-PS 0-2~* Expected survival \> 3 months~* Ability to complete self-administered questionnaires. If the patient has a motor disability (hemibody deficit) that does not allow to complete himself the questionnaires, these will be read by a CRA of the Neurosurgery department who will outline the questions without making any comment.~* A non-opposition form must have been completed by the patient~Exclusion Criteria:~* Previous cancer (\< 5 years) except of carcinoma of cervix uteri, basal cell or squamous cell skin carcinoma adequately treated~* Previous brain radiotherapy~* Neurological pathology with cognitive disorders existing before the study~* Having a contraindication for MRI~* Associated leptomeningeal disease~* Patients having another severe or uncontrolled pathology which could compromise the participation at the study (such as infection, cardiovascular, digestive, renal or pulmonary disease)~* Pregnant or breastfeeding woman. The women must not breastfeed for at least 6 months~* Impossibility to submit to the medical examinations of the study due to geographic, social or mental reasons

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- questionnaire administration (Type: EXPERIMENTAL): Quality of life questionnaires administration (EORTC QLQ C30 and BN20 / IADL / HADS / MoCa Edmonton Symptom Assessment Scale)

Based on this trial design, predict the completion outcome and termination type (if applicable).